NCT02865395

Brief Summary

Ureteroscopy is a common procedure in Urology that patients undergo daily to deal with a variety of ailments. These procedures often require that the bladder be filled and emptied with sterile water or saline several times during the procedure, and often result in the patient receiving a catheter at the end of the procedure. One common side effect is that patients experience bladder spasm or discomfort for a period of time after these procedures. Belladonna and Opium (B and O) suppositories and PO Oxybutynin are often given in the post-operative setting to relieve these symptoms. The principle objectives of this study are:

  1. 1.To determine if the addition of a B and O supprette suppository at the end of cystoscopic/ureteroscopic procedures reduces the incidence of bladder spasms and urinary discomfort that patients experience in the post-operative setting.
  2. 2.To determine if using peri-operative B and O supprette suppositories reduces the need for pos-operative oral Ditropan and use of narcotic pain medications.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2016

Completed
13 days until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 12, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

February 20, 2019

Completed
Last Updated

February 20, 2019

Status Verified

February 1, 2019

Enrollment Period

1.3 years

First QC Date

February 17, 2016

Results QC Date

December 26, 2018

Last Update Submit

February 19, 2019

Conditions

Keywords

Belladonna and Opium Suppositories

Outcome Measures

Primary Outcomes (1)

  • Post-operative Morphine Equivalent Dose

    No results collected on the post-operative morphine equivalent dose

    24 hours

Secondary Outcomes (1)

  • Post-Operative Pain

    24 hours

Study Arms (3)

Pre-operative Suppository

EXPERIMENTAL

A B\&O Suppository will be placed in the patient's rectum after the induction of anesthesia, but before the surgery.

Drug: Belladonna and Opium Suppository

Post-operative Suppository

ACTIVE COMPARATOR

A B\&O Suppository will be placed in the patient's rectum while still under anesthesia, but after the surgery.

Drug: Belladonna and Opium Suppository

Rectal Exam

PLACEBO COMPARATOR

Patient's will be given a rectal exam after the procedure but while still under anesthesia to serve as a placebo.

Procedure: Rectal Exam

Interventions

Post-operative SuppositoryPre-operative Suppository
Rectal ExamPROCEDURE
Rectal Exam

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing lithotripsy procedure at GW Hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

George Washington University

Washington D.C., District of Columbia, 20037, United States

Location

MeSH Terms

Conditions

Urinary Bladder, Overactive

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Patrick Mufarrij
Organization
George Washington University

Study Officials

  • Patrick Mufarrij

    George Washington University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Urology Resident

Study Record Dates

First Submitted

February 17, 2016

First Posted

August 12, 2016

Study Start

March 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

February 20, 2019

Results First Posted

February 20, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations